OAM
BIIB icon

Origin Asset Management’s Biogen BIIB Stock Holding History

Origin Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,182
Closed -$1.75M – 97
2020
Q3 		$1.75M Sell
6,182
-6,318
-51% -$1.76M 0.19% 37
2020
Q2 		$3.34M Sell
12,500
-1,200
-9% -$361K 0.49% 24
2020
Q1 		$4.33M Sell
13,700
-19,500
-59% -$5.92M 0.56% 19
2019
Q4 		$9.85M Hold
33,200
– – 0.82% 26
2019
Q3 		$7.73M Sell
33,200
-5,900
-15% -$1.37M 0.71% 43
2019
Q2 		$9.14M Sell
39,100
-19,700
-34% -$4.55M 1.02% 32
2019
Q1 		$13.9M Buy
58,800
+11,800
+25% +$3.72M 1.16% 39
2018
Q4 		$14.1M Sell
47,000
-15,900
-25% -$5.07M 1.29% 30
2018
Q3 		$22.2M Buy
62,900
+25,500
+68% +$8.78M 1.45% 27
2018
Q2 		$10.9M Sell
37,400
-47,900
-56% -$13.5M 0.77% 54
2018
Q1 		$23.4M Sell
85,300
-7,200
-8% -$2.23M 1.47% 23
2017
Q4 		$29.5M Sell
92,500
-3,800
-4% -$1.22M 1.69% 21
2017
Q3 		$30.2M Sell
96,300
-2,700
-3% -$800K 1.85% 19
2017
Q2 		$26.9M Hold
99,000
– – 1.65% 22
2017
Q1 		$27.1M Buy
99,000
+5,750
+6% +$1.63M 1.68% 19
2016
Q4 		$26.4M Buy
93,250
+1,700
+2% +$504K 1.74% 15
2016
Q3 		$28.7M Buy
+91,550
New +$27.1M 1.82% 17
2015
Q3 		– Sell
-80,392
Closed -$32.5M – 103
2015
Q2 		$32.5M Sell
80,392
-6,989
-8% -$2.8M 2.36% 9
2015
Q1 		$36.9M Buy
87,381
+9,374
+12% +$3.69M 2.72% 4
2014
Q4 		$26.5M Buy
78,007
+4,807
+7% +$1.56M 2.01% 10
2014
Q3 		$24.2M Buy
+73,200
New +$24.1M 1.57% 25

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Origin Asset Management's BIIB Position: Q4 2020 in Review

Origin Asset Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 6,182 shares — an estimated $1.75M sold.

Origin Asset Management first reported a position in BIIB in Q3 2014 and held it in 21 quarters. The position peaked at $36.9M in Q1 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Origin Asset Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Origin Asset Management sold 6,182 Biogen shares in Q4 2020, an estimated $1.75M.
  • Origin Asset Management first reported a position in Biogen in Q3 2014 and held it in 21 quarters.
  • Origin Asset Management's Biogen position peaked at $36.9M in Q1 2015.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Origin Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.